Recent advances in the diagnosis and treatment of pheochromocytoma

Kidney and Blood Pressure Research

Volumn 29, Issue 5, 2006, Pages 321-326

  Widimský Jr , Jiri ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Pheochromocytoma; Pheochromocytoma, blood pressure; Pheochromocytoma, diagnosis and treatment; Pheochromocytoma, genetic analysis

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CYCLOPHOSPHAMIDE; DOXAZOSIN; ESMOLOL; FLUORODOPAMINE F 18; ISOSORBIDE DINITRATE; LABETALOL; METADRENALIN; METIROSINE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 PROTEIN; NEUROFIBROMIN; NITROPRUSSIDE SODIUM; NORMETADRENALIN; PHENOXYBENZAMINE; PRAZOSIN; PROTEIN; PROTEIN RET; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE D; TERAZOSIN; TRACER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILMANDELIC ACID; VON HIPPEL LINDAU PROTEIN;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATECHOLAMINE BLOOD LEVEL; CHROMAFFIN CELL; CIRCADIAN RHYTHM; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOCRINE SURGERY; ENZYME SUBUNIT; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC SCREENING; GERM LINE; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; METASTASIS; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SIPPLE SYNDROME; SURGICAL APPROACH; TACHYCARDIA; TREATMENT OUTCOME; URINALYSIS; URINE LEVEL; VON HIPPEL LINDAU DISEASE;

ADRENAL GLAND NEOPLASMS; BLOOD PRESSURE; HUMANS; PHEOCHROMOCYTOMA;

EID: 33845918414     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097262     Document Type: Review

References (26)

1. McNeil AR, Blok BH, Koelmeyer TD, et al: Phaeochromocytoma discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust NZ J Med 2000;30:648-652.
2. Štrauch B, Zelinka T, Hampf M, Bernhardt R, Widimský J Jr: Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003;17:349-352.
3. Manger WM, Eisenhofer G: Pheochromocytoma: diagnosis and management update. Curr Hypertens Rep 2004;6:477-484.
4. Kaplan NM: Clinical Hypertension. Philadelphia, Lippincott Williams & Wilkins, 2006, pp 1-518.
5. Zelinka T, Štrauch B, Pecen L, Widimský J Jr: Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 2004;18:107-111.
6. Zelinka T, Widimský J Jr, Weisserová J: Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytoma. Physiol Res 2001;50:631-634.
7. Kikuya M, Hozawa T, Ohkubo T, Tsuji I, Michimata M, Matsubara M, et al: Prognostic significance of blood pressure and heart rate variabilities. The Ohasama study. Hypertension 2000;36:901-906.
8. Zelinka T, Štrauch B, Petrák O, Holaj R, Vranková A, Weisserová H, Pacák K, Widimský J Jr: Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. J Hypertens 2005;23:2033-2039.
9. Neumann HP, Bausch B, McWhinney SR, et al for the Freiburg-Warsaw- Columbus Pheochromocytoma Study Group: Germline mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-1466.
10. Lenders JWM, Eisenhofer G, Mannelli M, Pacák K: Pheochromocytoma. Lancet 2005;366:665-675.
11. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressacde Paillerets B, Chabre O, Chamo ntin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP: Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812-8818.
12. Eisenhofer G, Keiser H, Friberg P, et al: Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 1998;83:2175-2185.
13. Lenders JW, Pacák K, Walther MM, et al: Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002;287:1427-1434.
14. Goldstein DS, Eisenhofer G, Flynn JA, et al: Diagnosis and localisation of pheochromocytoma. Hypertension 2004;43:907-910.
15. Bravo EL, Tagle R: Pheochromocytoma: state of the art and future prospects. Endocr Rev 2003;24:539-553.
16. Kudva YC, Sawka AM, Young WF Jr, et al: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab 2003;88:4533-4539.
17. Bravo EL, Tarazi RC, Fouad FM, Vidt DG, Gifford RW Jr: Clonidine suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med 1981;305:623-626.
18. Eisenhofer G, Goldstein DS, Walther MM, et al: Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive results. J Clin Endocrinol Metab 2003;88:2656-2666.
19. Mukherjee JJ, Peppercorn PD, Reznek RH, et al: Pheochromocytoma: effect of non-ionic contrast medium in CT on circulating catecholamine levels. Radiology 1997;202:227-231.
20. 18F]fluorodopamine positron emission tomographic scanning for diagnostic localisation of pheochromocytoma. Hypertension 2001;38:6-8.
21. Ilias I, Pacák K: Current approaches and recommended algorithm for the diagnostic localisation of pheochromocytoma. J Clin Endocrinol Metab 2004;89:479-491.
22. Prys-Roberts C: Pheochromocytoma - recent progress in its management. Br J Anaesth 2000;85:44-57.
23. Janetschek G, Finkenstdt G, Gasser R, et al: Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol 1998;160:330-334.
24. Sprung J, O'Hara JF Jr, Gill IS, Abdelmalak B, Sarnaik A, Bravo EL: Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma. Urology 2000;55:339-343.
25. Plouin PF, Chatellier G, Fofol I, Corvol P: Tumour recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 1997;29:1133-39.
26. 131I-MIBG therapy for 12 patients with malignant pheochromocytoma. Cancer 2003;98:239-248.